Nektar Therapeutics | NKTR - Ebitda





Ebitda Veränderung Datum
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
ALKERMES USD 139.22M 58.96M 2026-06
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Amgen USD 3.86B 1.28B 2026-03
Baxter International USD 309M 756M 2026-03
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 649.7M 76.5M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cipla INR 14.03B 4.48B 2026-06
Dr.Reddys Laboratories INR 8.6B 2.14B 2026-06
Eisai JPY 34.15B 34.48B 2026-06
Eli Lilly USD 10.29B 1.86B 2026-03
Exelixis USD 255.4M 2.89M 2026-06
Gilead Sciences USD 3.51B 489M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Grifols EUR 482.04M 7.04M 2025-09
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
MacroGenics USD -30.2M 52.15M 2026-03
Merck USD -1.54B 7.84B 2026-03
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Pfizer USD 6.01B 18M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Takeda JPY 364.46B 214.21B 2026-06
Teva Pharmaceutical Industries USD 474M 581M 2026-06
Xencor USD -34.63M 86.74M 2026-06